Another study group evaluated 236 Ashkenazi Jewish PD patients in four different groups based on their mutation profile: LRRK2-PD, GBA1, GBA1-LRRK2-PD, and mutation-negative PD (MNPD). The gene discussed is LRRK2; the disease is Parkinson disease.